ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Kansas City, KS

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Ovarian Cancer
Squamous Cell Carcinoma of Head and Neck
Neoplasm Metastasis

Breast Cancer trials near Kansas City, KS, USA:

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer. (BRIA-ABC)

Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...

Enrolling
Breast Cancer
Breast Neoplasm
Drug: Cyclophosphamide
Drug: Interferon infiltration of the inoculation site

Phase 3

BriaCell Therapeutics

Kansas City, Kansas, United States and 35 other locations

growth factor receptor-2 negative (HER2-) advanced/metastatic breast cancer who received no prior cyclin-dependent kinase targeting...

Enrolling
Metastatic Breast Cancer
Drug: Elacestrant

Phase 2

Stemline Therapeutics
Stemline Therapeutics

Merriam, Kansas, United States and 33 other locations

Study combination use of cisplatin plus romidepsin and nivolumab in metastatic triple negative breast cancer (TNBC) or BRCA mutatio ...

Active, not recruiting
Breast Cancer
Triple-Negative Breast Cancer
Drug: Cisplatin
Drug: Romidepsin

Phase 1, Phase 2

Priyanka Sharma

Kansas City, Kansas, United States and 6 other locations

Recently updated

participants with metastatic or locally advanced Hormone Receptor (HR) positive and Human Epidermal Growth Factor Receptor (HER)2-negative breast...

Active, not recruiting
Breast Cancer
Locally Advanced Breast Cancer
Drug: Samuraciclib
Drug: Fulvestrant

Phase 2

Carrick Therapeutics

Kansas City, Missouri, United States and 31 other locations

The standard treatment for women with stage I, II, and III triple-negative breast cancer (TNBC) includes chemotherapy and surgery, ...

Active, not recruiting
Triple-negative Breast Cancer
Drug: Pegfilgrastim
Drug: Carboplatin

Phase 2

University of Kansas
University of Kansas

Kansas City, Kansas, United States and 8 other locations

together. A side effect is anything a drug does besides treating cancer.Participants in this trial have HER2-positive (HER2+) breast...

Active, not recruiting
HER2 Positive Breast Cancer
Drug: trastuzumab deruxtecan
Drug: tucatinib

Phase 2

Seagen, a wholly owned subsidiary of Pfizer

Kansas City, Missouri, United States and 32 other locations

The Phase 2 part of the trial will evaluate the efficacy and safety of the various combinations in patients with ER+/HER2- advanced/metastatic breast...

Enrolling
Breast Cancer
Metastatic Breast Cancer
Drug: Elacestrant
Drug: Everolimus

Phase 1, Phase 2

Stemline Therapeutics
Stemline Therapeutics

Merriam, Kansas, United States and 115 other locations

This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab
Drug: Trastuzumab deruxtecan

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Kansas City, Missouri, United States and 226 other locations

postmenopausal women with locally advanced or metastatic ER+/HER2- breast cancer with an acquired ESR1 mutation and who have diseas...

Active, not recruiting
Locally Advanced or Metastatic Breast Cancer
Drug: Lasofoxifene
Drug: Fulvestrant

Phase 2

Sermonix Pharmaceuticals

Kansas City, Missouri, United States and 50 other locations

The purpose of this study will be to evaluate, in a multi-center setting, the ability of radiofrequency ablation (RFA) of breast cancer...

Active, not recruiting
Breast Cancer
Device: Radiofrequency Ablation
University of Arkansas
University of Arkansas

Westwood, Kansas, United States and 5 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems